Omeprazole.
Omeprazole is the first acid-pump inhibitor. With its unique mechanism of action, it represents a new class of drugs in treatment of GERD, reflux esophagitis, and hypersecretory conditions. Overall, its adverse effects are mild and transient and found to be well-tolerated. Thus, omeprazole will serve as an important new agent in the management of some gastrointestinal disorders.